220 related articles for article (PubMed ID: 25617886)
1. Detection of methylation of the promoter region of the MAL and CADM1 genes by pyrosequencing in cervical carcinoma.
Mersakova S; Visnovsky J; Holubekova V; Nachajova M; Kudela E; Danko J; Lasabova Z
Neuro Endocrinol Lett; 2014; 35(7):619-23. PubMed ID: 25617886
[TBL] [Abstract][Full Text] [Related]
2. The Role of
Holubekova V; Mersakova S; Grendar M; Snahnicanova Z; Kudela E; Kalman M; Lasabova Z; Danko J; Zubor P
Genet Test Mol Biomarkers; 2020 May; 24(5):256-263. PubMed ID: 32311274
[No Abstract] [Full Text] [Related]
3. DNA methylation in human papillomavirus-infected cervical cells is elevated in high-grade squamous intraepithelial lesions and cancer.
Kim MK; Lee IH; Lee KH; Lee YK; So KA; Hong SR; Hwang CS; Kee MK; Rhee JE; Kang C; Hur SY; Park JS; Kim TJ
J Gynecol Oncol; 2016 Mar; 27(2):e14. PubMed ID: 26768780
[TBL] [Abstract][Full Text] [Related]
4. Follow-up of high-risk HPV positive women by combined cytology and bi-marker CADM1/MAL methylation analysis on cervical scrapes.
Verhoef VM; van Kemenade FJ; Rozendaal L; Heideman DA; Bosgraaf RP; Hesselink AT; Melchers WJ; Massuger LF; Bekkers RL; Steenbergen RD; Berkhof J; Snijders PJ; Meijer CJ
Gynecol Oncol; 2015 Apr; 137(1):55-9. PubMed ID: 25667975
[TBL] [Abstract][Full Text] [Related]
5. CADM1 and MAL promoter methylation levels in hrHPV-positive cervical scrapes increase proportional to degree and duration of underlying cervical disease.
Bierkens M; Hesselink AT; Meijer CJ; Heideman DA; Wisman GB; van der Zee AG; Snijders PJ; Steenbergen RD
Int J Cancer; 2013 Sep; 133(6):1293-9. PubMed ID: 23456988
[TBL] [Abstract][Full Text] [Related]
6. Methylation of
Meršaková S; Holubeková V; Grendár M; Višňovský J; Ňachajová M; Kalman M; Kúdela E; Žúbor P; Bielik T; Lasabová Z; Danko J
Oncol Lett; 2018 Dec; 16(6):7166-7174. PubMed ID: 30546453
[TBL] [Abstract][Full Text] [Related]
7. Combined CADM1 and MAL promoter methylation analysis to detect (pre-)malignant cervical lesions in high-risk HPV-positive women.
Overmeer RM; Louwers JA; Meijer CJ; van Kemenade FJ; Hesselink AT; Daalmeijer NF; Wilting SM; Heideman DA; Verheijen RH; Zaal A; van Baal WM; Berkhof J; Snijders PJ; Steenbergen RD
Int J Cancer; 2011 Nov; 129(9):2218-25. PubMed ID: 21190187
[TBL] [Abstract][Full Text] [Related]
8. Role of genomic DNA methylation in detection of cytologic and histologic abnormalities in high risk HPV-infected women.
Dankai W; Khunamornpong S; Siriaunkgul S; Soongkhaw A; Janpanao A; Utaipat U; Kitkumthorn N; Mutirangura A; Srisomboon J; Lekawanvijit S
PLoS One; 2019; 14(1):e0210289. PubMed ID: 30608989
[TBL] [Abstract][Full Text] [Related]
9. CADM1, MAL and miR124-2 methylation analysis in cervical scrapes to detect cervical and endometrial cancer.
De Strooper LM; van Zummeren M; Steenbergen RD; Bleeker MC; Hesselink AT; Wisman GB; Snijders PJ; Heideman DA; Meijer CJ
J Clin Pathol; 2014 Dec; 67(12):1067-71. PubMed ID: 25281766
[TBL] [Abstract][Full Text] [Related]
10. Performance of CADM1/MAL-methylation analysis for monitoring of women treated for high-grade CIN.
Uijterwaal MH; van Zummeren M; Kocken M; Luttmer R; Berkhof J; Witte BI; van Baal WM; Graziosi GCM; Verheijen RHM; Helmerhorst TJM; van Dijken DKE; Spruijt JWM; van Kemenade FJ; Fransen-Daalmeijer N; Bekker-Lettink M; Heideman DAM; Snijders PJF; Steenbergen RDM; Meijer CJLM
Gynecol Oncol; 2016 Oct; 143(1):135-142. PubMed ID: 27430395
[TBL] [Abstract][Full Text] [Related]
11. Methylation of Cervical Neoplastic Cells Infected With Human Papillomavirus 16.
Ki EY; Lee KH; Hur SY; Rhee JE; Kee MK; Kang C; Park JS
Int J Gynecol Cancer; 2016 Jan; 26(1):176-83. PubMed ID: 26552048
[TBL] [Abstract][Full Text] [Related]
12. Methylated Host Cell Gene Promoters and Human Papillomavirus Type 16 and 18 Predicting Cervical Lesions and Cancer.
Milutin Gašperov N; Sabol I; Planinić P; Grubišić G; Fistonić I; Ćorušić A; Grce M
PLoS One; 2015; 10(6):e0129452. PubMed ID: 26057381
[TBL] [Abstract][Full Text] [Related]
13. Hypermethylation of the tumor-suppressor cell adhesion molecule 1 in human papillomavirus-transformed cervical carcinoma cells.
Woo HJ; Kim SJ; Song KJ; Kim SS; Yoon CH; Choi BS; Rhee JE
Int J Oncol; 2015; 46(6):2656-62. PubMed ID: 25845528
[TBL] [Abstract][Full Text] [Related]
14. CADM1, MAL, and miR124 Promoter Methylation as Biomarkers of Transforming Cervical Intrapithelial Lesions.
Del Pino M; Sierra A; Marimon L; Martí Delgado C; Rodriguez-Trujillo A; Barnadas E; Saco A; Torné A; Ordi J
Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31067838
[TBL] [Abstract][Full Text] [Related]
15. CADM1 and MAL methylation status in cervical scrapes is representative of the most severe underlying lesion in women with multiple cervical biopsies.
van Baars R; van der Marel J; Snijders PJ; Rodriquez-Manfredi A; ter Harmsel B; van den Munckhof HA; Ordi J; del Pino M; van de Sandt MM; Wentzensen N; Meijer CJ; Quint WG
Int J Cancer; 2016 Jan; 138(2):463-71. PubMed ID: 26219541
[TBL] [Abstract][Full Text] [Related]
16. Development of a multiplex methylation-specific PCR as candidate triage test for women with an HPV-positive cervical scrape.
Snellenberg S; De Strooper LM; Hesselink AT; Meijer CJ; Snijders PJ; Heideman DA; Steenbergen RD
BMC Cancer; 2012 Nov; 12():551. PubMed ID: 23176198
[TBL] [Abstract][Full Text] [Related]
17. Methylation in host and viral genes as marker of aggressiveness in cervical lesions: Analysis in 543 unscreened women.
Fiano V; Trevisan M; Fasanelli F; Grasso C; Marabese F; da Graça Bicalho M; de Carvalho NS; Maestri CA; Merletti F; Sacerdote C; De Marco L; Gillio-Tos A
Gynecol Oncol; 2018 Nov; 151(2):319-326. PubMed ID: 30172480
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive CADM1 promoter methylation analysis in NSCLC and normal lung specimens.
van den Berg RM; Snijders PJ; Grünberg K; Kooi C; Spreeuwenberg MD; Meijer CJ; Postmus PE; Smit EF; Steenbergen RD
Lung Cancer; 2011 Jun; 72(3):316-21. PubMed ID: 21067843
[TBL] [Abstract][Full Text] [Related]
19. Methylomics analysis identifies epigenetically silenced genes and implies an activation of β-catenin signaling in cervical cancer.
Chen YC; Huang RL; Huang YK; Liao YP; Su PH; Wang HC; Chang CC; Lin YW; Yu MH; Chu TY; Lai HC
Int J Cancer; 2014 Jul; 135(1):117-27. PubMed ID: 24310984
[TBL] [Abstract][Full Text] [Related]
20. The RASSF1A tumor suppressor gene is commonly inactivated in adenocarcinoma of the uterine cervix.
Cohen Y; Singer G; Lavie O; Dong SM; Beller U; Sidransky D
Clin Cancer Res; 2003 Aug; 9(8):2981-4. PubMed ID: 12912945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
